#DiabetesCare #CardiovascularHealth #GLP1 #SGLT2 #RealWorldEvidence #Semaglutide #Empagliflozin #Dulaglutide #HealthOutcomes #Type2Diabetes UPMC University of Pittsburgh School of Medicine Suresh Mulukutla Kevin Kip Lara Lemon, PhD, PharmD Love this, Anum
Studies have shown that Tirzepatide has been shown to reduce inflammation of cytokines such as TNF-, IL-6, and CRP
These mechanisms contribute to its broad regenerative effects observed in animal models across musculoskeletal, gastrointestinal, and systemic systems
BPC-157 has never received FDA drug approval
Aggressive angiomyxoma of the penis: the first case report in a 9-month-old infant
According to the Frank-Starling law of the heart, this should result in lower blood pressure (indeed, early clinical trials show this to be the case)